FleishmanHillard Fishburn has appointed MHP’s former MD and head of global health, John Gisborne, as MD of its healthcare team.
Gisborne joins FleishmanHillard Fishburn’s executive committee with a brief to build and enhance the agency’s healthcare team within its global network.
With more than ten years’ senior experience, he spent the last seven years at MHP. Before that, he headed up Hill+Knowlton Strategies’ international healthcare practice, as well as its Medical Knowledge Group in London.
He also led the company’s European Centre of Excellence in healthcare.
While Gisborne’s specialty sector is healthcare and pharmaceuticals, he has also advised businesses in the energy, supply chain and FMCG sectors. A biochemist by training, he has a particular interest in key issues in the healthcare sector such as medicines pricing, value assessment and complex approval processes.
He was also appointed board director and trustee of the International FH (Familial Hypercholesterolaemia) Foundation in 2013.
Jim Donaldson, CEO, UK and Middle East, said: “Bringing John Gisborne on board to lead one of our biggest teams is a great coup for FleishmanHillard Fishburn. John is a very experienced leader and one of the top names in healthcare communications, not just in the UK but across the region, with a history of running very significant teams with great success.”
Gisborne added: “The health sector is currently responding to so many technological advancements and possibilities, with great expectation from society. In these times, effective communications is all-important and we are well-placed to help current and new clients expand the impact it can have on their businesses.”